DescriptionI am co-organising with Dr James Wright (The Alan Turing Institute), co-chairing and presenting my research at the panel ‘AI in Health and Care: Development, Governance, and Ethics in East Asia.’ Discussants: Professor Selma Šabanović (Indiana University) and Professor Yulia Frumer (Johns Hopkins). Presenters include: Dr David Leslie (The Alan Turing Institute); Dr Anne Stefanie Aronsson (University of Zurich); Professor Chihyung Jeon & Dr Heesun Shin (Korea Advanced Institute of Science and Technology); Professor Seonsam Na (University of Oxford) and Professor Eunjeong Ma (Pohang University of Science and Technology); Professor Tsujimura Mayuko (Chiba University) and Professor Naonori Kodate (University College Dublin). Virtual event.
|Period||6 Jun 2022 → 10 Jun 2022|
|Location||London, United KingdomShow on map|
|Degree of Recognition||International|
- Social Robots
- East Asia
- Healthy Ageing
Documents & Links
Discourses around the future potential and imagined impacts of AI are reaching new heights of aspiration globally. In particular, Japan - with the world’s most rapidly ageing society - published a major national AI Strategy in 2019. The document is imbued with a rhetoric of AI ‘saving’ the country from current and future societal crises that has long characterised national policy around techno-science (Šabanović 2014; Frumer 2018; Robertson 2018; Wright 2019). Similar rhetoric is also found in South Korea, China, Singapore, and Taiwan, which have published a flurry of national AI strategy documents since 2017. This panel critically examines how AI and related technologies such as socially assistive robots and the internet of things are imagined or expected to transform futures of health and social care in these countries, and how key actors in the government, industry, and third sector propose that they be governed. Focusing on cases from East Asia, we invite a critical discussion drawing on the following questions: - What forms of AI and related technologies, such as robotics, are actually being developed and deployed in health and care? - How does the aspirational rhetoric of AI connect with realities of use? - How are the ethics and governance of AI systems being conceptualised, drawn up into guidelines and principles, and operationalised? - Where is the “human” in “human-centric AI”? And who or what does a “human-centric AI” exclude?